Discovery of Ruthenium(II) Metallocompound and Olaparib Synergy for Cancer Combination Therapy-Reference-Cited by-同舟云学术

Discovery of Ruthenium(II) Metallocompound and Olaparib Synergy for Cancer Combination Therapy

Published:2023-05-15 Issue:10 Volume:66 Page:6922-6937
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Yusoh Nur Aininie¹,Tiley Paul R.²,James Steffan D.²,Harun Siti Norain³,Thomas Jim A.⁴^ORCID,Saad Norazalina¹,Hii Ling-Wei⁵,Chia Suet Lin¹⁶,Gill Martin R.²^ORCID,Ahmad Haslina¹³

Affiliation:

1. UPM-MAKNA Cancer Research Laboratory, Institute of Bioscience, Universiti Putra Malaysia, UPM, 43400 Serdang, Selangor, Malaysia

2. Department of Chemistry, Faculty of Science and Engineering, Swansea University, Swansea SA2 8PP, U.K.

3. Department of Chemistry, Faculty of Science, Universiti Putra Malaysia, UPM, 43400 Serdang, Selangor, Malaysia

4. Department of Chemistry, University of Sheffield, Sheffield S3 7HF, U.K.

5. Center for Cancer and Stem Cell Research, Development and Innovation (IRDI), Institute for Research, International Medical University, Kuala Lumpur 57000, Malaysia

6. Department of Microbiology, Faculty of Biotechnology and Biomolecular Science, Universiti Putra Malaysia, UPM, 43400 Serdang, Selangor, Malaysia

Funder

Royal Society of Chemistry

Llywodraeth Cymru

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.3c00322

Reference67 articles.

1. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease